- $5.35bn
- $6.09bn
- $4.92bn
- 88
- 60
- 47
- 71
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,856 | 4,034 | 4,540 | 4,885 | 4,922 |
Cost of Revenue | |||||
Gross Profit | 684 | 793 | 937 | 1,119 | 1,102 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,588 | 3,666 | 4,085 | 4,386 | 4,453 |
Operating Profit | 268 | 368 | 455 | 499 | 469 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 270 | 357 | 441 | 482 | 501 |
Provision for Income Taxes | |||||
Net Income After Taxes | 212 | 272 | 338 | 355 | 375 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 212 | 272 | 338 | 355 | 375 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 212 | 272 | 338 | 355 | 375 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 2.99 | 4 | 4.9 | 5.66 | 6.44 |